AMC Entertainment just delivered a Q1 revenue beat — domestic box office jumped 22% — yet the lending market for its stock has simultaneously reached maximum tightness, creating an unusually charged backdrop as short sellers rebuild positions and one analyst finally turns bullish.
The clearest tension right now is in the borrow market. Every share available to lend is now out on loan — availability has collapsed to 0%, matching the 52-week extreme and leaving no slack in the lending pool. That is the tightest the market has been for AMC all year, and it arrived abruptly: availability was around 40% as recently as last Monday. Cost to borrow has climbed to 1.63%, up 20% on the week and 64% over the past month, though in absolute terms it remains modest. The squeeze pressure is structural, not yet punishing — but the setup is worth watching.
Short interest tells the other half of the story, and it is not one of capitulation. At roughly 18.7% of the free float, short positioning is elevated and trending higher — up nearly 12% over the past week, adding around 10 million shares since last Monday. That is a notable rebuilding after a sharper retreat in March and early April, when shorts were cut from above 19% to a trough near 14%. Bulls who thought the covering was structural are now watching that unwind with no available shares left to borrow. The ORTEX short score has drifted up to 69.8, the highest reading in the current series, and the percentile rank on availability ranks in the 1st percentile universe-wide — meaning this is about as tight as it gets.
The analyst picture shifted on Wednesday morning. Benchmark's Mike Hickey upgraded AMC from Hold to Buy with a fresh $2.50 target — the only material change among active analysts and notable because it arrived the same day Q1 earnings were released. The broader analyst distribution remains cautious: two Buys sit alongside four Holds, with Citigroup maintaining a Sell. The mean target of $2.02 implies roughly 27% upside from the current $1.59 close, though that average is dragged higher by Wedbush's $4.00 target from July 2025 and Benchmark's new $2.50 — the bear-case voices (Citi at $1.10, Macquarie and Roth Capital at $1.50) are considerably more sceptical. The bull case leans on a strong 2026 film slate, projected EBITDA growing 53% this year, and net leverage potentially falling toward 7x by year-end. Bears point to high fixed costs, persistent attendance headwinds, and an EPS miss on the Q1 print despite the revenue beat.
Options positioning is unexpectedly light on defensive pressure. The put/call ratio dropped to 0.17 — well below its 20-day average of 0.19 and near the 52-week low of 0.14 — suggesting options traders leaned into calls ahead of the earnings release rather than buying downside protection. That contrasts sharply with the story in the lending market, where demand for borrows has surged. The divergence is notable: options flow is risk-on while the short book is being rebuilt, not reduced.
The new Arena One partnership — launching live interactive concerts across 300-plus AMC locations from June — is the non-film catalyst management is pitching alongside the box office recovery narrative. Whether it moves the needle on EBITDA is a 2026 back-half question, but it frames the next earnings print on August 4 as a test of two things at once: whether the domestic box office momentum holds into summer, and whether an operationally leveraged cost base can finally convert top-line growth into positive EBITDA. With availability fully exhausted and short interest rebuilding, any meaningful revenue surprise in either direction has an unusually compressed borrow market to run through.
See the live data behind this article on ORTEX.
Open AMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
